Once established in the lung, monocytes rapidly differentiate into macrophages initiated by a complex process after transendothelial migration out of the bloodstream. 8 Because recruitment of MNPs and PMNs is an early event within the inflammatory cascade, a specific tracking of these cells would be an ideal target for a molecular imaging approach to visualize pulmonary inflammation in the initial stage.
MRI is not currently used to assess patients with acute lung diseases because conventional proton-based ( 1 H) MRI does not provide more specific data than conventional chest radiographs, which would justify the effort of performing MRI in critically ill patients. Additionally, the lung is not typically appraised by MRI because of respiratory motion and sparse proton density due to large amounts of air with relatively small amounts of tissue. The latter further exacerbates the imaging challenge faced by MRI because the many air-tissue interfaces in the lung substantially reduce the apparent T 2 relaxation time and give rise to pronounced susceptibility artifacts. To date, MRI of the lung airways is possible with inhaled contrast agents 10 and of the lung parenchyma with image acquisition strategies that use ultrashort echo times. 11 However, ultrashort echo time MRI of the lung tissue mainly relies on the accumulation of water protons as consequence of tissue damage and leaky membranes, thereby enabling a diagnosis only in advanced stages of disease. The early visualization of cell infiltration associated with inflammatory processes by MRI up until now used predominantly superparamagnetic and ultrasuperparamagnetic iron oxide particles, taking advantage of the high affinity of these compounds for the monocyte-macrophage system. 12 Yet, this approach is ill suited to lung imaging, because these particles lead to a depletion of the MR signal, and under normal conditions the lungs already appear quite dark in 1 H MRI.
In the present study, we examined the feasibility of imaging pulmonary inflammation with a positive 19 F contrast agent. For this purpose, we used emulsified perfluorocarbons (PFCs), which are biochemically inert and are phagocytized similar to superparamagnetic iron oxide particles 13 and which we have recently shown to be suitable for visualizing inflammatory processes associated with cardiac and cerebral ischemia. 14 Because of the lack of any natural 19 F background, the observed signals exhibit a high degree of specificity for areas of inflammation. We aimed to investigate whether 19 F MRI is capable of (1) imaging lung inflammation under conditions where superparamagnetic iron oxide particles fail and (2) detecting inflammatory processes in an initial stage before any structural alterations to the lung.
Methods
An expanded Methods section can be found in the online-only Data Supplement.
Preparation of PFC Emulsion
The PFC emulsion containing of 10% wt/wt perfluoro-15-crown-5 ether was prepared essentially as previously reported (see Data Supplement for more details). 14 
Animal Experiments
All experiments were performed in accordance with the national guidelines on animal care and were approved by the Bezirks-regierung Düsseldorf. NMRI mice (20 to 30 g body weight [BW], 8 to 12 weeks of age, nϭ60) were bred at the Tierversuchsanlage of Heinrich-Heine-Universität, Düsseldorf, Germany.
Induction of Lipopolysaccharide-Mediated Pulmonary Inflammation
Lipopolysaccharide (LPS) from Salmonella enteriditis (Sigma, Taufkirchen, Germany) was dissolved at 1 mg/mL in sterile 0.9% saline and diluted to the concentrations reported for the individual experiments. For intratracheal instillation of isoflurane-anesthetized mice, the LPS solution was gently introduced at the distal end of the tube. To avoid volume-induced damage to the lung, no pressure was applied and the solution was instead instilled by the spontaneous respiration of the mouse. Sham mice were instilled intratracheally with 1.5 L/g BW LPS-free sterile 0.9% saline, whereas control mice received no instillation. For therapy studies, drugs were dissolved in DMSO and the respective solutions were injected with a microsyringe twice daily (1 L/g BW) into the subcutaneous tissue beginning 30 minutes before LPS challenge. Mice were administered dexamethasone (1 g/g BW per day), CGS21680 (2 g/g BW per day), or vehicle control (DMSO 1 L/g BW). Six hours after the induction of pneumonia, 500 L of the PFC emulsion was injected through the tail vein and the first MRI investigation was carried out 18 hours after the injection of the PFC contrast agent (see supplemental Figure 1 for a detailed scheme of the animal protocol).
MRI
MRI was performed 24 and 48 hours after induction of pulmonary inflammation essentially as previously described. 14 Data were acquired on a Bruker 9.4-T NMR spectrometer using a 30-mm birdcage resonator tuneable to 1 H and 19 F. After acquisition of the morphological 1 H images, the resonator was tuned to 19 F and anatomically matching 19 F images were recorded (see Data Supplement for a more detailed description of MRI setup, acquisition parameters, and quantification procedures).
Blood Analysis
Blood was obtained from the inferior vena cava, and mononuclear cells were isolated from the blood samples by centrifugation over Histopaque density gradients (for details, see Data Supplement).
Lung Preparation for Wet-to-Dry Weight Measurements or Flow Cytometric Analysis
Mice were deeply anesthetized with ketamine/xylazine i.p. After opening of the thorax, the heart and lungs were excised and blood was removed. After surgical preparation, lungs were used for determination of wet-to-dry (W/D) weight ratios or processed for flow cytometric analysis according to standard procedures (see Data Supplement for details).
Immunohistochemistry
Frozen sections (10 m) were cut from organs of animals that received LPS and PFCs after 24 or 48 hours. Lung sections were fixed and processed for immunohistochemistry according to standard procedures (see Data Supplement for details).
Statistics
All data are given as meanϮSEM. A level of PϽ0.05 was considered statistically significant (see Data Supplement for additional details on the statistical analysis).
Results
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and MNPs into lung tissue. 15, 16 Six hours after LPS application, 500 L of 10% perfluoro-15-crown-5 ether emulsion (average size, Ϸ130 nm; potential, Ϫ31.3Ϯ1.5 mV) was injected via the tail vein. Animals were imaged 24 and 48 hours after LPS challenge. 1 H fast gradient echo (GE) and fast spin echo (RARE) MRI were acquired to assess structural alterations in the lung via developing hyperintense areas. Subsequently, anatomically matching 19 F images were recorded for localizing the injected PFCs.
A typical example of consecutively recorded 1 H and 19 F images obtained 24 and 48 hours after induction of pulmonary inflammation with 0.3 g/g BW LPS is illustrated in Figure 1 . GE images of the thorax acquired after LPS ( Figure 1A , left) show some signals arising from flowing blood within pulmonary vessels next to the heart, which were also detectable under control conditions (data not shown). The anatomic matching RARE imageswhere signals from protons in motion (eg, blood vessels and heart) are not visible and thus allow a more specific attribution of evolving hyperintense regions-also gave no evidence for any alterations within the lung at 24 hours after LPS ( Figure 1A and 1B, left). There were as well no differences detected between control and sham-instilled animals ( Figure 2A ). However, the corresponding 19 F image clearly demonstrates the accumulation of PFCs in both lobes of the lung ( Figure 1C and 1D, left). Because the fast spin echo pulse sequence (RARE) used to acquire the 19 F images was similar to that used for 1 H images, signals from circulating fluorine are also suppressed and the 19 F signals detected by this method can therefore be assigned unambiguously to PFCs deposited in lung tissue. Only at 48 hours after LPS could anatomically corresponding signals be detected by 1 H MRI ( Figure 1A and 1B, right). Note that the 19 F signals obviously preceded the colocalized hyperintense regions in GE and RARE images detected one day later by 1 H MRI (Figures 1 and 2 ). Without LPS, at no time were 19 F signals observed within the lung (supplemental Figure 2 ).
F Signals Correlate With LPS Dose and Pathological Markers of Lung Inflammation
From the data summarized in Figure 2 , it can be seen that 19 F signals obtained 24 hours after LPS challenge showed For merging of data sets (D), a hot iron color table was applied to the 19 F images. On day 1, 19 F MRI clearly detected the accumulation of PFCs in both lung lobes, whereas no hyperintense signals were observed in 1 H-derived images. Follow-up 1 H MRI investigation on day 2 revealed bilateral infiltrates in the same anatomic region where 19 F signals were observed at day 1. a strong correlation with the applied LPS dose over a wide concentration range (0.06 to 1.5 g/g BW LPS, nՆ5 per group) and exceeded background noise levels already at only 0.15 g/g BW (Figure 2A , PϽ0.05). At the same time, 1 H MRI only revealed signs of lung injury in the group treated with the highest dose tested (1.5 g/g BW), which was also the sole group to exhibit a transient alteration in body temperature (⌬t mean : 1.7Ϯ0.5°C). After 48 hours, data pattern obtained from both nuclei did not differ any longer from each other ( Figure 2B ). Note that the 19 F signal at 0.15 g/g BW LPS after 48 hours was significantly lower than the respective value at 24 hours (PϽ0.05), suggesting washout of the PFC label (Figure 2A and 2B). Determination of lung W/D weight ratios after 48 hours revealed LPS dose-dependent increases in W/D ratio that reached statistical significance at 0.3 g/g BW LPS as compared with sham application of saline (5.49Ϯ0.10 versus 4.64Ϯ0.38 mg/mg, nϭ6 each, PϽ0.01).
To demonstrate that the acquired 19 F signals of LPSchallenged lungs relate to phagocyte invasion, tissue sections were processed for immunohistochemistry. Microscopic survey images after Cy3 staining for Mac-2 (also known as galectin-3) as marker for macrophages exhibited a fluorescence pattern comparable to that observed for the 19 F signal in the corresponding MRI ( Figure 3A and 3B). Higher magnification ( Figure 3C ) reveals that substantial numbers of Mac-2-positive cells were located in the lung parenchyma and the small airways (bronchioli).
Uptake and Transport of PFCs by Phagocytes
To define more closely the cell populations that transport PFCs to the lung, blood samples were subjected to density gradient centrifugation at different points in time (2 to 72 hours) after injection of PFCs. The time course of PFC uptake and their distribution in the different cell populations was then assessed by 1 H and 19 F MRI, as illustrated in Figure 4 for a representative experiment. As can be seen, MRI-detectable 19 F signals were observed from 2 to 12 hours after administration of the contrast agent to be preferentially associated with the MNP and PMN fractions, whereas after 24 and 48 hours the signal within the MNPs dominated. After 72 hours, however, the PFCs were completely cleared from the bloodstream. The temporal development of PFC distribution was similar in LPStreated animals ( Figure 4B ) compared with untreated control animals ( Figure 4A ). From the quantified data reported in supplemental Table 1 , it can be seen that peak 19 F signal intensities were found in both groups 12 hours after PFC injection.
To further identify the cells within the inflamed tissue that carry the 19 F label, LPS-challenged lungs (1.5 g/g BW LPS) were excised and enzymatically digested, and the resulting cell populations were sorted by flow cytometry. After digestion approximately 150ϫ10 6 cells were harvested per lung, and the expression levels of F4/80 (MNPs), clone 7/4 (PMNs), CD19 ϩ (B cells), and CD3 ϩ (T cells) were analyzed by fluorescence-activated cell sorting (FACS) ( Figure 5A ). Consistent with data from the literature, 16 the most prominent leukocyte fraction within the lung after LPS challenge was found to be PMNs with 24.1Ϯ6.1%, followed by MNPs with 10.5Ϯ0.9%, whereas B and T cells comprised only 0.9Ϯ0.3% and 1.5Ϯ0.4%, respectively (nϭ4). All sorted cell fractions were then analyzed by 1 H/ 19 F MRI to determine the degree of 19 F labeling. Figure 5B demonstrates that the most prominent 19 F signals were found in the monocyte (MNP) fraction and to a lesser extent in neutrophils (PMNs), although the number of PMNs was almost 3-fold higher than that of MNPs (supplemental Table 2 ). To be able to evaluate PFC load at the level of individual cells, 19 F signal intensities were calibrated with PFC concentration standards and related to the absolute numbers of the respective cell population as derived from the FACS analysis. This calculation revealed a PFC content of 12.8Ϯ3.7 fmol/cell for MNPs and 1.5Ϯ0.7 fmol/cell for PMNs, whereas T and B cells were not labeled.
Monitoring of Therapeutic Interventions by 19 F MRI
In the final set of experiments, we investigated whether this novel imaging approach could also be used to assess the efficacy of anti-inflammatory therapy. Toward this end, animals were treated 30 minutes before LPS challenge by subcutaneous injection with either the glucocorticoid dexamethasone (DEX, 1 g/g BW/d)-a clinically wellestablished anti-inflammatory drug 17 -or CGS21680 (CGS, 2 g/g BW/d), an adenosine 2A receptor agonist, which has previously been used to prevent lung injury in models of hemorrhagic shock. 18 Just as above, intravenous 19 F MRI. Anti-inflammatory treatment was performed with dexamethasone (DEX, 1 g/g BW), the adenosine 2A receptor agonist CGS21680 (CGS, 2 g/g BW), and vehicle (DMSO, 1 L/g BW) after pulmonary challenge with LPS (0.3 g/g BW). Quantification of 1 H and 19 F MR signals in the lung 24 hours after induction of pneumonia revealed that only 19 F MRI could differentiate between treated and untreated groups at this early point in time (nϭ6 each, **PϽ0.001 versus vehicle). application of the PFC emulsion was carried out 6 hours thereafter followed by 1 H/ 19 F MRI after 24 and 48 hours. Pharmacological treatment was continued twice daily within the observation period. Quantification of pulmonary 19 F signals 24 hours after LPS revealed that both DEX and CGS treatment inhibited PFC accumulation by Ϸ80% ( Figure 6 ; nϭ6 per group, PϽ0.001). Consistent with our previous findings, 1 H MRI failed to reveal significant alterations 24 hours after LPS.
To relate the results obtained by in vivo 19 F MRI to pathological markers of pulmonary inflammation, lungs were excised after MRI at 48 hours and processed for determination of lung W/D weight ratios and numbers of infiltrating leukocytes. From the data summarized in Figure 7 , it can be seen that during continuing therapy 19 F signals in both the DEX and CGS groups were still strongly depressed after 48 hours ( Figure 7A; nϭ6, PϽ0.001) . Similarly, both lung W/D weight ratios ( Figure 7B ) and numbers of PMNs and MNPs ( Figure 7C and 7D) found within the lung were considerably diminished (PϽ0.001).
To exclude the possibility that the reduced 19 F signal intensity observed during drug treatment was caused by an altered PFC loading of infiltrating cells, we also analyzed the 19 F content of leukocytes in the blood after density gradient centrifugation similar to experiments shown in Figure 4 . In DEX-and CGS-treated animals, 19 F signal intensities from blood collected after LPS challenge were determined to be 119Ϯ36 and 96Ϯ13 arbitrary units, respectively, revealing no substantial differences in PFC loading between treated and untreated groups (120Ϯ10 arbitrary units at 12 hours after LPS; see supplemental Table 1 ).
Discussion
In the present study, we demonstrate in a murine model of acute lung injury that nanoemulsions of PFCs can be used to sensitively localize foci of pulmonary inflammation as hot spots by simultaneous acquisition of morphologically matched proton ( 1 H) and fluorine ( 19 F) MRIs. Injected PFCs are primarily phagocytized by monocytes and to a lesser extent by neutrophils, resulting in early detectable 19 F MRI signals as a consequence of progressive infiltration of the labeled immunocompetent cells into inflamed areas, at a time when 1 H MRI provided no evidence of lung injury. Because of the lack of any 19 F background in the body, the observed signals are robust and exhibit an excellent degree of specificity. Quantification of 19 F foci in experiments with stepwise increasing LPS doses and antiinflammatory treatment indicated that the severity of the induced pneumonia is reflected by the signal intensity in the 19 F images and illustrated that this approach is also suitable to monitor therapeutic interventions.
The early assessment of pulmonary inflammation by the applied technique is based on the detection of PFC-loaded monocytes, which are known to be quickly recruited to the lung in response to the LPS-induced release of chemokines. 19, 20 In contrast, the identification of inflamed areas in the lung via hyperintense regions by conventional 1 H MRI relies on an enhanced pulmonary proton density caused by plasma extravasation into the lung interstitium. In our LPS study, as in bacterial models of murine pneumonia, detection of pulmonary inflammation in conventional 1 H images was not possible until 2 days after the induction of pneumonia, 21, 22 permitting only a delayed diagnosis at a time when the disease is already in an advanced state. Similarly, the diffuse opacities observed on radiographs are related to significant alterations in lung tissue density that develop only at advanced stages of pneumonia. The sensitivity of 1 H MRI for pulmonary inflammation may be improved by loading circulating monocytes, similar to what we described for 19 F, with 1 H-detectable contrast agents, such as iron oxide-or gadolinium-containing compounds. However, a direct quantification of the observed signals, as is feasible for the background-free 19 F images, may not be easily achieved, particularly in the case of signal-depleting iron oxidebased contrast agents. Even signal-amplifying gadoliniumbased contrast agents may prove difficult to quantitate in absolute terms, because the cellular uptake of the contrast agent complicates appropriate calculations. For this, the effective relaxation enhancement by the gadoliniumcontaining compound is required, but, after internalization of the contrast agent, this essential parameter has recently been demonstrated not to be constant and critically dependent on both the intracellular localization and concentration of the gadolinium-containing compound. 23 Furthermore, cellular uptake and prolonged persistence of gadolinium within the body may increase the risk of side effects such as nephrogenic systemic fibrosis. 24 There may be unwanted side effects with PFCs as well, in particular because the injectate volume used here was relatively large for a mouse (500 L). However, contrast injection was well tolerated, and additional experiments in our laboratory have shown that inflammatory processes can be detected in mice with as little as 50 L of a 10% PFC-containing emulsion (unpublished data). Furthermore, we and others so far have not observed any adverse reactions, neither on animals after PFC injection nor on the proliferation, function, or maturation of immune cells after incorporation of the fluorine label. 14, 25, 26 The reasons underlying this inert behavior are probably related to (1) the strength of the C-F bond, which is resistant to any cleavage by endogenous enzymes, and (2) the dense and repellent electron sheath that coats F-chains, resulting in extremely weak intermolecular interactions. 27 The physiological inertness of PFCs is further supported by our data showing that both PFC-loaded monocytes and neutrophils are still capable of responding to pulmonary LPS challenge within a period of time, which is in good agreement with previous data suggesting an unaltered infiltration kinetics for the labeled cells. 8 At this point, it is important to note that the LPS challenges used here were within a moderate range, because a transient alteration of body temperature was only observed at the highest dose tested. However, PFC deposition in the lung was also observed by 19 F MRI at substantially lower doses of LPS emphasizing that (1) PFC-loaded leukocytes properly responded to threshold stimuli, and (2) 19 F MRI can detect pulmonary inflammation well in advance of conventional physiological methods and proton MRI. The threshold dose of LPS at which PFC deposition in the lung became significant was 0.15 g/g BW. Interestingly, at this dose 19 F signal intensity peaked after 24 hours and substantially decreased from 24 to 48 hours (Figure 2A and 2B) , which suggests that also transient adhesion of monocytes after minor challenges can be monitored with this approach.
Our study clearly delineates the mechanisms that are involved in inflammation imaging by 19 F MRI. Experiments combining blood density gradient centrifugation, FACS analysis, and 1 H/ 19 F MRI revealed that intravenously applied PFCs are phagocytized predominantly by MNPs and are thereafter transported to the area of inflammation. Our study cannot exclude the possibility that under LPS challenge, resident alveolar macrophages or activated leukocytes adhering to the venular endothelium after pulmonary injury 28 also incorporated some circulating PFCs and may have contributed to the observed 19 F signals. However, because we never observed fluorine signals above the background noise level in lungs without LPS application, at least under control conditions, this uptake would appear to be negligible. Consistent with the short half-life of monocytes, 29 the PFC label persisted for approximately 48 hours within the circulation, as we also reported previously. 14 In follow-up to our prior study, here we also noted a minor PFC uptake by PMNs, which is probably related to the different mouse strains used. In the present study, we used NMRI mice, whereas our previous investigation was conducted using C57BL/6 mice. On the other hand, this observation indicates that exploiting differences in surface properties of target cells and retargeting of liposomes by coupling with antibodies may be a promising future option to extend the diagnostic utility of 19 F MRI.
In the current study, our initial approach to image inflammation in the heart and brain 14 is now extended to the lung-an organ that poses serious challenges to all imaging modalities because it generally appears dark and without contrast. As discussed in detail above, both conventional chest radiography and 1 H MRI require substantial alterations in pulmonary tissue density before inflammatory processes can be recognized, thereby providing a diagnosis only in advanced stages of the disease. The identification of pulmonary inflammation by 19 F MRI-at a time when the inflammatory cascade is just being initiated by chemokine release and the recruitment of monocytes 7,30 -opens the possibility of earlier detection and more timely therapeutic intervention, provided that the early infiltration kinetics of inflammatory cells in human pulmonary diseases is similar to that of mice.
Because of the biochemical inertness of PFCs and the high MR sensitivity of the fluorine nucleus, 19 F MRI may be applicable for clinical inflammation imaging. Fluorine coils can readily be interfaced with clinical scanners and the development of dedicated 19 F phased-array multichannel coils, as used for coronary angiography by 1 H MRI, should overcome signal-to-noise problems associated with the transition from small-animal MRI at high field to larger MRI scanners for human use. 31 The PFC used in this study (perfluoro-15-crown-5 ether) exhibits ideal MR properties but has a retention time within the body, which is too long 14 to be suitable for repetitive human applications. There are, however, a variety of other PFCs that have been evaluated clinically as artificial blood substitute 27 and that are known to be quickly cleared from the body through exhalation by the lungs. Viewed from the MRI perspective, these compounds have the disadvantage that when 19 F images are acquired in a conventional manner, they give rise to chemical shift artifacts due to signal splitting resulting from magnetically different 19 F nuclei, but this problem can be overcome by advanced detection methods based on fast chemical shift imaging techniques. 32 
